Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SPRO
SPRO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SPRO News
Spero Therapeutics Reports Fourth Quarter Revenue of $41.3 Million
Mar 26 2026
moomoo
Spero Therapeutics Reports Strong Q4 Earnings
Mar 26 2026
seekingalpha
SPERO THERAPEUTICS REPORTS Q4 NET INCOME OF $31.52 MILLION
Mar 26 2026
moomoo
Spero Therapeutics Reports Q4 Operating Income of $31.405 Million
Mar 26 2026
moomoo
Spero Therapeutics Reports Q4 Operating Expenses of $9.892 Million
Mar 26 2026
moomoo
Spero Therapeutics and GSK Submit NDA for Tebipenem HBr, Triggering $25 Million Milestone Payment
Dec 19 2025
Globenewswire
Spero Therapeutics and GSK Submit NDA for Tebipenem HBr, Triggering $25M Milestone Payment
Dec 19 2025
Newsfilter
Spero Therapeutics Grants 90,000 RSUs to New Employee Under 2019 Inducement Plan
Nov 28 2025
Globenewswire
Spero Therapeutics Grants 90,000 RSUs to New Employee Under 2019 Inducement Plan
Nov 28 2025
Newsfilter
Most Active Stocks in Pre-Market on October 21, 2025: BYND, GSIT, SPRO, TSLL, IONZ, SQQQ, NIO, F, SMR, IONQ, GM, LAC
Oct 21 2025
NASDAQ.COM
PIVOT-PO Phase 3 Results Highlight Tebipenem HBr as a Promising First Oral Carbapenem Antibiotic for Complicated Urinary Tract Infections (cUTIs)
Oct 21 2025
Newsfilter
"ATA Creativity Global and Two Other Promising Low-Cost Stocks"
Sep 01 2025
Yahoo Finance
AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer
Jul 04 2025
NASDAQ.COM
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Jun 09 2025
Benzinga
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
May 31 2025
Benzinga
Pre-Market Most Active for May 30, 2025 : TSLL, BSLK, SQQQ, NVDA, TQQQ, IONQ, SPRO, LVWR, QBTS, BBAI, NIO, GAP
May 30 2025
NASDAQ.COM
Show More News
